KLOW Blend – 80mg
CA$175.00
Synergistic blend combining GHK-Cu, BPC-157, TB-500, and KPV are research peptides examined together for tissue repair, vascular formation, and cellular signalling in vitro.
This synthetic peptide blend combines four regenerative peptides into a single vial for studies examining complementary tissue regeneration and inflammation reduction pathways:
- GHK-Cu is a tripeptide complexed with copper ions and is evaluated in laboratory settings for its coordination chemistry, molecular conformation, and association behaviour under defined experimental conditions.
- TB-500 is a synthetic peptide corresponding to a segment of thymosin beta proteins and is examined for its structural properties and interaction behaviour within controlled laboratory systems.
- BPC-157 is a synthetic pentadecapeptide studied for sequence-dependent molecular behaviour, stability, and interaction patterns in non-human laboratory environments.
- KPV is a short peptide evaluated in laboratory research for its molecular structure, stability, and observed association behaviour within controlled experimental models.
Researchers can examine potential synergy across copper-mediated extracellular-matrix activation (GHK-Cu), cytoprotective signalling (BPC-157), actin-dependent cell motility (TB-500), and immune-modulatory pathways (KPV). In vitro and ex vivo models evaluate collagen deposition rates, angiogenic indices, inflammatory marker expression, and controlled tissue recovery metrics.
Composition: 80 mg lyophilized blend per vial
50 mg GHK-Cu | 10 mg BPC-157 | 10 mg TB-500 | 10 mg KPV
